34 results on '"Jensen, Lisette Okkels"'
Search Results
2. DIFFERENCES IN MANAGEMENT AND PROGNOSTICATION OF CARDIOGENIC SHOCK PATIENTS IN THE PRESENCE AND ABSENCE OF OUT-OF-HOSPITAL CARDIAC ARREST
3. Abstract 14012: The Importance of Right Bundle Branch Block in Suspected ST-Elevation Myocardial Infarction is Independent of ST-T Deviations
4. Outcome in Elderly Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction
5. Neutrophil Gelatinase-Associated Lipocalin (NGAL) Measured at Admission is Associated With Development of Late Cardiogenic Shock and Mortality in Patients With ST-Segment Elevation Myocardial Infarction
6. Invasive aortic pulse pressure is not superior to cuff pulse pressure in cardiovascular risk prediction
7. Culprit lesion morphology in patients with ST-segment elevation myocardial infarction assessed by optical coherence tomography
8. Clinical outcomes three-year after revascularization with biodegradable polymer stents: ultrathin-strut sirolimus-eluting stent versus biolimus-eluting stent: from the Scandinavian organization for randomized trials with clinical outcome VII trial
9. Randomized Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent With the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated With Percutaneous Coronary Intervention: The SORT OUT IX Trial
10. Admission Leukocyte Count is Associated with Late Cardiogenic Shock Development and All-Cause 30-Day Mortality in Patients with St-Elevation Myocardial Infarction
11. Lactate is a Prognostic Factor in Patients Admitted With Suspected ST-Elevation Myocardial Infarction
12. Plasma Concentration of Biomarkers Reflecting Endothelial Cell- and Glycocalyx Damage are Increased in Patients With Suspected ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock
13. Coronary artery disease and risk of adverse cardiac events and stroke
14. A 10-Month Angiographic and 4-year Clinical Outcome of Everolimus-Eluting Versus Sirolimus-eluting Coronary Stents in Patients With Diabetes Mellitus (The Diabedes IV Randomized Angiography Trial)
15. Randomized comparison of a sirolimus-eluting Orsiro stent with a biolimus-eluting Nobori stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for Randomized Trials with Clinical Outcome VII trial
16. Influence of multivessel disease with or without additional revascularization on mortality in patients with ST-segment elevation myocardial infarction
17. The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: Ischemic postconditioning or deferred stent implantation versus conventional primary angioplasty and complete revascularization versus treatment of culprit lesion only: Rationale and design of the DANAMI 3 trial program
18. Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: From Western Denmark heart registry
19. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: The randomized diabetes and drug-eluting stent (DiabeDES) IV intravascular ultrasound trial
20. Outcomes after primary percutaneous coronary intervention in octogenarians and nonagenarians with ST-segment elevation myocardial infarction: From the Western Denmark heart registry
21. Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart disease
22. Outcome and safety of same-day-discharge percutaneous coronary interventions with femoral access: A single-center experience
23. Incidence of Definite Stent Thrombosis or In-Stent Restenosis after Drug-Eluting Stent Implantation for Treatment of Coronary In-Stent Restenosis: from Western Denmark Heart Registry
24. Health Care System Delay and Heart Failure in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Follow-up of Population-Based Medical Registry Data
25. Zotarolimus-eluting versus sirolimus-eluting coronary stent implantation
26. System Delay and Mortality Among Patients With STEMI Treated With Primary Percutaneous Coronary Intervention
27. Rationale and Design of a Randomized Clinical Comparison of Everolimus-Eluting (Xience V/Promus) and Sirolimus-Eluting (Cypher Select+) Coronary Stents in Unselected Patients with Coronary Heart Disease
28. Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention
29. Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: The Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial
30. Recruitable collateral blood flow index predicts coronary instent restenosis after percutaneous coronary intervention
31. Intravascular ultrasound assessment of remodelling and reference segment plaque burden in type-2 diabetic patients
32. Target lesion revascularisation in patients treated with a sirolimus-eluting or paclitaxel-eluting stent
33. Intravascular ultrasound assessment of fibrous cap remnants after coronary plaque rupture
34. Effect of Simvastatin on Coronary Lesion Site Remodeling: A Serial Intravascular Ultrasound Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.